HAI
MRNA icon

Hennessy Advisors Inc’s Moderna MRNA Stock Holding History

Hennessy Advisors Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,400
Closed -$1.53M – 314
2023
Q4 		$1.53M Hold
15,400
– – 0.08% 249
2023
Q3 		$1.59M Sell
15,400
-400
-3% -$44.6K 0.11% 182
2023
Q2 		$1.92M Sell
15,800
-400
-2% -$53.4K 0.14% 180
2023
Q1 		$2.49M Sell
16,200
-500
-3% -$82.5K 0.18% 163
2022
Q4 		$3M Sell
16,700
-1,000
-6% -$164K 0.2% 156
2022
Q3 		$2.09M Sell
17,700
-400
-2% -$60.7K 0.14% 205
2022
Q2 		$2.59M Sell
18,100
-400
-2% -$57.2K 0.15% 185
2022
Q1 		$3.19M Buy
+18,500
New +$3.11M 0.17% 183

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hennessy Advisors Inc's MRNA Position: Q1 2024 in Review

Hennessy Advisors Inc sold out of Moderna (MRNA) in Q1 2024, closing a stake of 15,400 shares — an estimated $1.53M sold.

Hennessy Advisors Inc first reported a position in MRNA in Q1 2022 and held it in 8 quarters. The position peaked at $3.19M in Q1 2022. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Hennessy Advisors Inc reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Hennessy Advisors Inc sold 15,400 Moderna shares in Q1 2024, an estimated $1.53M.
  • Hennessy Advisors Inc first reported a position in Moderna in Q1 2022 and held it in 8 quarters.
  • Hennessy Advisors Inc's Moderna position peaked at $3.19M in Q1 2022.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Hennessy Advisors Inc's 13F filing for Q1 2024, filed 16 Apr 2024.